IRIS
SPECCHIA, GIORGINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.591
EU - Europa 1.944
AS - Asia 1.156
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.701
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.584
CN - Cina 853
IE - Irlanda 710
UA - Ucraina 600
SE - Svezia 383
TR - Turchia 155
FI - Finlandia 92
SG - Singapore 86
GB - Regno Unito 61
IN - India 59
IT - Italia 27
FR - Francia 21
DE - Germania 18
RU - Federazione Russa 15
CZ - Repubblica Ceca 9
CA - Canada 7
AT - Austria 5
AU - Australia 5
EU - Europa 4
CH - Svizzera 1
ES - Italia 1
HK - Hong Kong 1
IR - Iran 1
JP - Giappone 1
MK - Macedonia 1
NZ - Nuova Zelanda 1
Totale 5.701
Salva come PNG Salva come JPEG
Città #
Dublin 708
Chandler 503
Jacksonville 425
Dearborn 357
Nanjing 263
Nyköping 210
Nanchang 118
Beijing 87
San Mateo 86
Princeton 85
Boardman 78
Wilmington 75
Ashburn 50
Singapore 50
Shenyang 49
Jiaxing 42
Kunming 40
Tianjin 40
Woodbridge 26
Hebei 25
Changsha 20
Des Moines 19
Hangzhou 19
Jinan 17
Zhengzhou 17
Guangzhou 14
Changchun 13
New York 12
Ningbo 11
Shanghai 11
Auburn Hills 10
Helsinki 10
Chicago 8
Lanzhou 8
Los Angeles 7
Hilden 6
Norwalk 6
Wuhan 6
Brno 5
Monza 5
Taizhou 5
Leawood 4
Olomouc 4
Toronto 4
Ann Arbor 3
Jinhua 3
London 3
Munich 3
Pune 3
San Giorgio Ionico 3
Shaoxing 3
Augusta 2
Brisbane 2
Chatsworth 2
Cremona 2
Delhi 2
Foggia 2
Fremont 2
Hefei 2
Houston 2
Milan 2
Moose Jaw 2
Redwood City 2
Saint Petersburg 2
San Severo 2
Simi Valley 2
Springfield 2
Stevenage 2
Washington 2
Athlone 1
Auckland 1
Baotou 1
Bari 1
Buffalo 1
Chelyabinsk 1
Davis 1
Dongyang 1
Drogheda 1
Ficarazzi 1
Fort Worth 1
Fuzhou 1
Gosford 1
Haikou 1
Hanover 1
High Wycombe 1
Hong Kong 1
Hyderabad 1
Kyoto 1
L'aquila 1
Lausanne 1
Leeds 1
Mcallen 1
Modugno 1
Montréal 1
Moscow 1
Palermo 1
Paris 1
Perth 1
Qingdao 1
Quanzhou 1
Totale 3.646
Salva come PNG Salva come JPEG
Nome #
T-cell acute lymphoblastic leukemia occurring in a patient with acute promyelocytic leukemia. 108
Mobilization of haematopoietic stem cells CD34+ in patients undergoing elective lung resection: observational pilot study 94
E2A-PBX1 fusion in adult acute lymphoblastic leukaemia: biological and clinical features. 91
Acute megakaryoblastic leukemia: experience of GIMEMA trials. 88
Extramedullary blast crisis in chronic myeloid leukemia 86
Autoimmune myelofibrosis: report of three cases and review of the literature. 85
A chronic myelocytic leukemia case bearing deletions on the three chromosomes involved in a variant t(9;22;11). 84
Human monocyte-derived dendritic cells exposed to hyperthermia show a distinct gene expression profile and selective upregulation of IGFBP-6 84
A fluorescence in situ hybridization study of complex t(9;22) in two chronic myelocytic leukemia cases with a masked Philadelphia chromosome. 83
Prophylaxis against infections with low-dose intravenous immunoglobulins (IVIG) in chronic lymphocytic leukemia. Results of a crossover study. 82
Continuous infusion chemotherapy with epirubicin and vincristine in relapsed and refractory acute leukemia. 82
Response to fludarabine in B-cell chronic lymphocytic leukemia patients previously treated with chlorambucil as up-front therapy and a CHOP-like regimen as second line therapy. 81
Doxorubicin and m-AMSA induced DNA damage in blast cells from AML patients. 79
Submicroscopic deletions in an acute myeloid leukemia case with a four-way t(8;11;16;21). 77
Molecular cytogenetic characterization of deletions on der(9) in chronic myelocytic leukemia. 75
t(15;17) in acute promyelocytic leukemia is not associated with submicroscopic deletions on der(17) 75
Adenosine deaminase activity in chronic lymphocytic leukemia: evaluation of lymphocytic ADA during and after treatment. 75
Cytotoxicity and DNA damage caused by 4-demethoxydaunorubicin and its metabolite 4-demethoxy-13-hydroxydaunorubicin in human acute myeloid leukemia cells. 74
Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. 74
Detection of BCR/ABL rearrangements in adult acute lymphoblastic leukemia using a highly sensitive interphase fluorescence in situ hybridization method (D-FISH). 74
Evaluation of trisomy 12 by fluorescence in situ hybridization in peripheral blood, bone marrow and lymph nodes of patients with B-cell chronic lymphocytic leukemia. 73
Concomitant tetrasomy 3q and trisomy 18 in CD5(-), CD13(+) chronic lymphocytic leukemia. 73
CIZ gene rearrangements in acute leukemia: report of a diagnostic FISH assay and clinical features of nine patients. 72
A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol 72
Neutrophilic-chronic myeloid leukemia: low levels of p230 BCR/ABL mRNA and undetectable BCR/ABL protein may predict an indolent course. 71
CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy. 70
Acute myeloblastic leukemia with minimal myeloid differentiation featuring a three-way translocation t(8;13;14) 70
A novel chromosomal translocation t(3;7)(q26;q21) in myeloid leukemia resulting in overexpression of EVI1. 70
Cytochemical "normal" and "abnormal" eosinophils in acute leukemias. 70
A case of Sezary's syndrome with terminal "leukemic phase". 70
CD2 expression in acute promyelocytic leukemia is associated with microgranular morphology (FAB M3v) but not with any PML gene breakpoint. 70
Cytotoxic activity and mechanism of action of 5-Aza-2'-deoxycytidine in human CML cells. 69
Invasive infections caused by Trichosporon species and Geotrichum capitatum in patients with hematological malignancies: a retrospective multicenter study from Italy and review of the literature 69
Fungemia in acute leukemia patients: a single institution's experience. 68
Identification of new partner chromosomes involved in fusions with the ETV6 (TEL) gene in hematologic malignancies. 68
Angiogenesis and hereditary hemorrhagic telangiectasia. Rendu-Osler-Weber disease. 68
Non-treatment-related chronic myeloid leukemia as a second malignancy. 68
Clinico-biologic features and treatment outcome of adult pro-B-ALL patients enrolled in the GIMEMA 0496 study: absence of the ALL1/AF4 and of the BCR/ABL fusion genes correlates with a significantly better clinical outcome. 67
Sensitivity to imatinib but low frequency of the TEL/PDGFRb fusion protein in chronic myelomonocytic leukemia. 67
Mitoxantrone and continuous infusion of cytosine arabinoside in refractory and relapsed acute lymphoblastic leukemia. 67
Molecular cytogenetic characterization of a novel additional chromosomal aberration in blast crisis of a Ph-positive chronic myeloid leukemia. 66
Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. Gruppo Italiano Malattie Ematologiche Maligne Dell'Adulto. 66
Breakpoint characterization of der(9) deletions in chronic myeloid leukemia patients. 66
Familial clustering of HTLV-I infection in southeastern Italy 65
Derivative chromosome 9 deletions in chronic myeloid leukemia are associated with loss of tumor suppressor genes. 65
Extramedullary involvement in patients with acute promyelocytic leukemia: a report of seven cases. 65
Pneumonia in acute leukemia patients during induction therapy: experience in a single institution. 65
Extramedullary involvement at relapse in acute promyelocytic leukemia patients treated or not with all-trans retinoic acid: a report by the Gruppo Italiano Malattie Ematologiche dell'Adulto. 64
Monocytes with binding capacity to sheep red blood cells in a case of acute undifferentiated leukemia. 64
Monitoring of cardiac function on the basis of serum troponin I levels in patients with acute leukemia treated with anthracyclines. 64
Acute mixed lineage leukemias. 63
Molecular cytogenetic study of chromosomal instability at 1q21-32 in an adult acute lymphoblastic leukemia case. 63
Cytophagocytosis by the blast cells in acute myeloid leukemia. 63
Multilineage involvement in the 5q- syndrome: a fluorescent in situ hybridization study on bone marrow smears 62
Partial deletions of long arm of chromosome 6: biologic and clinical implications in adult acute lymphoblastic leukemia. 62
Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia. 62
Genomic deletions on the third chromosome involved in variant t(9;22) chronic myeloid leukaemia cases 62
Acute promyelocytic leukemia: morphological aspects. 61
Constitutive expression of IL-1 beta, M-CSF and c-fms during the myeloid blastic phase of chronic myelogenous leukaemia. 61
Characterization of a recurrent translocation t(2;3)(p15–22;q26) occurring in acute myeloid leukaemia. 61
A novel translocation t(2;9)(q14;p12) in AML-M2 with an uncommon phenotype: myeloperoxidase-positive and myeloid antigen-negative 61
Bone marrow aspirate on the 14th day of induction treatment as a prognostic tool in de novo adult acute myeloid leukemia. 61
Molecular cytogenetics characterization of a novel translocation involving chromosomes 17 and 19 in a Ph+ adult acute lymphoblastic leukaemia. 61
The MDR phenotype in acute nonlymphoid leukemia. 61
Ear involvement in acute promyelocytic leukemia at relapse: a disease-associated 'sanctuary'? 60
Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia. 59
The hypereosinophilic syndrome: fluorescence in situ hybridization detects the del(4)(q12)-FIP1L1/PDGFRA but not genomic rearrangements of other tyrosine kinases. 59
Outcome of patients with acute myeloid leukemia who failed to respond to a single course of first-line induction therapy: a GIMEMA study of 218 unselected consecutive patients. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. 59
Reciprocal translocation t(12;13)(p13;q14) in acute nonlymphoblastic leukemia: report and cytogenetic analysis of two cases. 59
Liquid chromatographic determination of urinary 5-methyl-2'-deoxycytidine and pseudouridine as potential biological markers for leukaemia. 59
Idarubicin (4-demethoxydaunorubicin) as single agent for remission induction of previously untreated acute promyelocytic leukemia: a pilot study of the Italian cooperative group GIMEMA 59
Typhlitis complicating induction therapy in adult acute myeloid leukemia. 59
Evaluation of leukemic contamination in peripheral blood stem cell leukaphereses vs bone marrow after consolidation therapy in acute myeloid leukemia: not a critical factor in outcome? 58
Ph positive acute lymphoblastic leukemia in adults: molecular and clinical studies. 57
Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study. 57
Interleukin-1 and tumor necrosis factor production in acute non-lymphoid leukemia. 57
Second malignancy after treatment of adult acute myeloid leukemia: cohort study on adult patients enrolled in the GIMEMA trials. 57
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. 56
Therapy of molecular relapse in acute promyelocytic leukemia. 56
Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche dell' Adulto. 55
Hand-mirror (HM) cells in acute lymphoblastic leukaemia (A.L.L.). An attempt at cellular classification by morphometric analytical parameters using the S.A.M. (Shape Analytical Morphometry) system. 54
Good and poor CD34+ cells mobilization in acute leukemia: analysis of factors affecting the yield of progenitor cells. 52
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia. 50
Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. 50
Immunophenotypic and molecular features of 'cuplike' acute myeloid leukemias 41
LIGHT/TNFSF14 as a new biomarker of bone disease in multiple myeloma patients experiencing therapeutic regimens 13
Totale 5.743
Salva come PNG Salva come JPEG
Categoria #
all - tutte 26.890
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.890
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020808 0 0 0 0 168 198 202 18 105 10 104 3
2020/2021641 88 1 85 1 87 93 88 7 87 98 2 4
2021/2022386 84 0 0 1 11 4 8 28 67 40 25 118
2022/20231.929 136 56 50 171 158 176 0 176 915 8 49 34
2023/2024246 78 11 16 16 28 49 3 12 3 1 2 27
2024/2025134 50 7 6 53 18 0 0 0 0 0 0 0
Totale 5.743